Calumet Inc (CLMT): Next-Year EPS Estimate 176.22%
As of 2026-08-25, Calumet Inc (CLMT) has a next-year EPS growth estimate of 176.22%. Featured in 4 EPS revision reports, most recently on 2026-08-17.
On 2026-08-25, analyst consensus for CLMT's next-year EPS growth shifted from 170.04% to 176.22% — a positive change of 6.18 percentage points. Current-year growth is projected at -534.62%.
What's Driving This
The primary structural driver is the analysts’ EPS estimate upgrade for next-year growth, which moved from 170.04% to 176.22%. This revision follows Calumet’s second-quarter 2026 results, highlighted by record Specialties performance, providing a concrete earnings catalyst. Momentum has persisted beyond the initial revision, with a net EPS change of +5.40 percentage points across two upward revisions and one downward revision.
Generated 2026-08-25 from news as of 2026-08-25
Current Snapshot
- Sector
- Basic Materials
- Industry
- Specialty Chemicals
- EPS growth next year
- 176.22%
- EPS growth this year
- -534.62%
- EPS next quarter (est)
- $1.38
- Last price
- $47.03
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-08-25 | 176.22% | -534.62% | $1.38 | $47.03 |
| 2026-08-24 | 170.04% | -446.03% | $1.09 | $47.32 |
| 2026-08-23 | 170.04% | -446.03% | $1.09 | $49.01 |
| 2026-08-21 | 170.04% | -446.03% | $1.09 | $49.01 |
| 2026-08-20 | 170.04% | -446.03% | $1.09 | $48.29 |
| 2026-08-19 | 170.04% | -446.03% | $1.09 | $49.19 |
| 2026-08-18 | 170.04% | -446.03% | $1.09 | $50.81 |
| 2026-08-17 | 170.04% | -446.03% | $1.09 | $48.35 |
| 2026-08-16 | 170.04% | -446.03% | $1.09 | $47.72 |
| 2026-08-14 | 170.04% | -446.03% | $1.09 | $47.72 |
| 2026-08-13 | 170.04% | -446.03% | $1.09 | $48.79 |
| 2026-08-12 | 170.04% | -446.03% | $1.09 | $47.19 |
| 2026-08-11 | 177.42% | -356.28% | $0.93 | $46.04 |
| 2026-08-10 | 177.42% | -356.28% | $0.93 | $45.47 |
| 2026-08-09 | 170.82% | -406.03% | $0.75 | $39.48 |
| 2026-08-07 | 159.11% | -420.35% | $0.36 | $39.48 |
| 2026-08-06 | 159.11% | -420.35% | $0.07 | $41.88 |
| 2026-08-05 | 159.11% | -420.35% | $0.07 | $40.26 |
| 2026-08-04 | 159.11% | -420.35% | $0.07 | $41.56 |
| 2026-08-03 | 159.11% | -420.35% | $0.07 | $42.37 |
| 2026-08-02 | 159.11% | -420.35% | $0.07 | $44.19 |
| 2026-07-31 | 159.11% | -420.35% | $0.07 | $44.19 |
| 2026-07-30 | 159.11% | -420.35% | $0.07 | $43.75 |
| 2026-07-29 | 159.11% | -420.35% | $0.07 | $42.40 |
| 2026-07-28 | 159.11% | -420.35% | $0.07 | $41.48 |
| 2026-07-27 | 159.11% | -420.35% | $0.07 | $41.28 |
| 2026-07-26 | 205.47% | -247.05% | $0.21 | $41.69 |
| 2026-07-24 | 205.47% | -247.05% | $0.21 | $41.69 |
| 2026-07-23 | 205.47% | -247.05% | $0.21 | $42.82 |
| 2026-07-22 | 205.47% | -247.05% | $0.21 | $44.14 |
Reports Featuring CLMT
- 2026-08-17
SNDK Soars 45.9% After EPS Revision, AI Memory Boom Fuels Rally
- 2026-08-13
SHAZ Surges 44.6% on AI Capacity Expansion; SNDK, ACB, CLMT, NYXH Follow
- 2026-07-21
FWRD Leads EPS Revision Surge with 26.7% Gain; AEHR, RCEL Follow
- 2026-07-20
RCEL leads with 27.9% gain on EPS revision; other healthcare stocks follow
Recent News
- Calumet Inc (CLMT) (Q2 2026) Earnings Call Highlights: Record Specialties Performance and ...GuruFocus.com
- Calumet Inc (CLMT) (Q2 2026) Earnings Call Highlights: Record Specialties Performance and ...GuruFocus.com
- Calumet Reports Second Quarter 2026 ResultsPR Newswire
- Calumet Reports Second Quarter 2026 ResultsPR Newswire
- Calumet Announces Board Member Will Not Stand for Re-ElectionPR Newswire
Screen Performance
Aggregate stats across all 2014 tickers our top-EPS-revision screen has flagged over the past 146 days.
- Median return since detection
- +3.1%
- % of tickers in the green
- 56%
- Median return on winners
- +19.9%
- Large revisions captured
- 1606
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Calumet Inc's next-year EPS growth estimate?▾
As of 2026-08-25, Calumet Inc (CLMT) has a next-year EPS growth estimate of 176.22%, based on analyst consensus.
When was the latest EPS estimate revision for CLMT?▾
The most recent revision occurred on 2026-08-25, when analysts adjusted the next-year EPS growth estimate from 170.04% to 176.22%.
What sector and industry does Calumet Inc belong to?▾
Calumet Inc operates in the Basic Materials sector, specifically the Specialty Chemicals industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. CLMT appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Calumet Inc (CLMT) appears here because it was detected by our daily top-EPS-revision-performer screen.